Exane Derivatives Constellation Brands, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Constellation Brands, Inc. stock. As of the latest transaction made, Exane Derivatives holds 160 shares of STZ stock, worth $27,433. This represents 0.02% of its overall portfolio holdings.
Number of Shares
160
Previous 163
1.84%
Holding current value
$27,433
Previous $37,000
-0.0%
% of portfolio
0.02%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding STZ
# of Institutions
1,345Shares Held
142MCall Options Held
3.69MPut Options Held
3M-
Vanguard Group Inc Valley Forge, PA18.4MShares$3.16 Billion0.06% of portfolio
-
Capital World Investors Los Angeles, CA12.8MShares$2.19 Billion0.4% of portfolio
-
Warren Buffett Berkshire Hathaway Inc | Omaha, Ne12MShares$2.06 Billion0.87% of portfolio
-
Black Rock Inc. New York, NY10.4MShares$1.78 Billion0.06% of portfolio
-
State Street Corp Boston, MA7.2MShares$1.24 Billion0.06% of portfolio
About CONSTELLATION BRANDS, INC.
- Ticker STZ
- Exchange NYSE
- Sector Consumer Defensive
- Industry Beverages—Wineries & Distilleries
- Shares Outstandng 161,224,000
- Market Cap $27.6B
- Description
- Constellation Brands, Inc., together with its subsidiaries, produces, imports, markets, and sells beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy. It provides beer primarily under the Corona Extra, Corona Premier, Corona Familiar, Corona Light, Corona Refresca, Corona Hard Seltzer, Modelo Especial, Modelo Neg...